Unity Biotechnology
 | |
| Company type | Public |
|---|---|
| Nasdaq: UBX Russell 2000 Index component | |
| Industry | Biotechnology, Pharmaceutical |
| Predecessor | Forge, Inc. |
| Founded | 2011 in California, United States of America |
| Founders | Jan van Deursen, Nathaniel “Ned” David |
| Headquarters | , |
Number of employees | 70 (2018) |
| Website | unitybiotechnology |
Unity Biotechnology is a startup biotechnology company that develops drugs which target senescent cells.[1][2][3][4][5][6][7]
The company's products in development include UBX0101, targeting knee osteoarthritis (in Phase I clinical trials as of June 2018), and UBX1967, a preclinical product targeting ophthalmologic diseases.[8][9] Both are senolytic medicines.
On May 3, 2018, the company went public on the Nasdaq exchange, raising $85 million at a market capitalization of $700 million. [10][9]
See also
References
- ^ Brueck, Hilary (3 February 2016). "Mayo Clinic Taps Silicon Valley to Help People Age Gracefully". Fortune. Retrieved 19 February 2018.
- ^ Detrixhe, John (21 February 2018). "Crypto millionaires are funding research to reverse the aging process". Quartz (publication). Retrieved 19 February 2018.
- ^ Herkewitz, William (19 February 2018). "Scientists Can Now Radically Expand the Lifespan of Mice—and Humans May Be Next". Popular Mechanics. Retrieved 19 February 2018.
- ^ Ramsey, Lydia (10 November 2016). "A biotech startup that aims to rid our bodies of cells related to aging just got a big investment". Business Insider. Retrieved 19 February 2018.
- ^ Scudellari, Megan (25 February 2017). "To Stay Young, Kill Zombie Cells". Scientific American. Retrieved 19 February 2018.
- ^ Greenfieldboyce, Nell (3 February 2016). "Boosting Life Span By Clearing Out Cellular Clutter". Retrieved 19 February 2018.
- ^ Baker, Darren (11 February 2016). "Naturally occurring p16Ink4a-positive cells shorten healthy lifespan". Nature. 530 (7589): 184–189. doi:10.1038/nature16932. PMC 4845101. PMID 26840489.
- ^ "S-1". www.sec.gov. Retrieved 2018-10-12.
- ^ a b "Longevity Company Unity Biotechnology Stocks Soared After CEO Talks to CNBC | BioSpace". BioSpace. Retrieved 2018-10-12.
- ^ CNBC (2018-05-02). "UNITY Biotechnology, Inc. Announces Pricing of Initial Public Offering of Common Stock". CNBC. Retrieved 2018-10-12.
External links
 | This United States corporation or company article is a stub. You can help Wikipedia by expanding it. |